Vikas R Dharnidharka. Show Affiliations »
Abstract
Mesh： See more » Antigens, CDAntigens, Differentiation/therapeutic useCTLA-4 AntigenDrug Therapy, CombinationEpstein-Barr Virus Infections/complicationsGraft Rejection/prevention & controlHumansImmunosuppressive Agents/therapeutic useKidney TransplantationLymphoproliferative Disorders/etiology
Substances： See more » Antigens, CDAntigens, DifferentiationCTLA-4 AntigenCTLA4 protein, humanImmunosuppressive Agents
Year: 2005 PMID： 16282187 DOI： 10.1056/NEJM200511103531919
Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245